A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round. . . . → Read More: Gene Therapy Delivery Company Gains $26M in Early Funds
|
|||||
       
  |
 Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray Comments are closed Intellectual property, New products biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K. 
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies Comments are closed Joint ventures/collaborations biomedical, biotechnology, chemistry, Europe, genomics, licensing, life sciences, pharmaceuticals, physical sciences 
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease. . . . → Read More: Trial Shows Synthetic Antibody Slows Cognitive Decline One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, clinical trials, Europe, life sciences, pharmaceuticals, physical sciences 
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines. . . . → Read More: Nasal Spray Shown to Stop Covid-19 Infection, Disease Comments are closed New products Australia, biomedical, biotechnology, chemistry, Covid-19, life sciences, pharmaceuticals, physical sciences, preclinical 
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition. . . . → Read More: RNA Manufacturer Goes Public in $282M Merger Comments are closed Finance agriculture, biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, equity, investment, IPO, life sciences, manufacturing, merger, physical sciences 
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour. . . . → Read More: Portable Testing Device IDs Covid-19 Variants One comment - (Comments are closed) New products biomedical, biotechnology, chemistry, Covid-19, engineering, genomics, life sciences, medical device, physical sciences, university 
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address. . . . → Read More: Protein Chemistry Biotech Acquired in $2B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, chemistry, entrepreneurs, Europe, investment, life sciences, merger, pharmaceuticals, physical sciences, preclinical 
Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases. . . . → Read More: Fine-Tuning Process Devised for Gene Therapies 2 comments - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, genomics, licensing, life sciences, patent, pharmaceuticals, physical sciences, preclinical 
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, Europe, investment, life sciences, materials science, medical device, physical sciences, university, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
